Voyager Therapeutics, Inc.
VYGR
Revenue
5.20M
▼-1.27M▼-19.67%
3 Months ChangeAssets
322.10M
▼-31.14M▼-8.82%
3 Months ChangeLiabilities
78.16M
▼-2.38M▼-2.96%
3 Months ChangeFree Cash Flow
-38.55M
▼-95.18M▼-168.08%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2024-09-05
Form 8-K
ID: 0001104659-24-097152
2024-08-06
Form 10-Q
ID: 0001558370-24-011073
2024-08-06
Form 8-K
ID: 0001558370-24-011071
2024-06-13
Form 8-K
ID: 0001104659-24-071048
2024-06-06
Form 8-K
ID: 0001104659-24-069063
2024-05-16
Form 8-K
ID: 0001104659-24-062257
2024-05-13
Form 10-Q
ID: 0001558370-24-007953
2024-05-13
Form 8-K
ID: 0001558370-24-007951
2024-04-02
Form 8-K
ID: 0001104659-24-042502
2024-03-13
Form 8-K
ID: 0001104659-24-033726